- Business Wire•17 days ago
CEL-SCI Corporation today announced it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $1.5 million in a registered direct offering.
- Accesswire•18 days ago
Upcoming AWS Coverage on TESARO Post-Earnings Results LONDON, UK / ACCESSWIRE / March 8, 2017 / Active Wall St. blog coverage looks at the headline from CEL-SCI Corp. (NYSE: CVM ) as the Company announced ...
- Business Wire•20 days ago
CEL-SCI Corporation announces that it has received the official minutes from its February 8, 2017 meeting with the U.S. Food and Drug Administration in regards to the partial clinical hold placed on the Phase 3 head and neck cancer study with CEL-SCI’s investigational drug Multikine* on September 26, 2016.
CVM : Summary for Cel-Sci Corporation ($0.001 Pa - Yahoo Finance
CEL-SCI Corporation (CVM)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Bid||0.08 x 5000|
|Ask||0.09 x 20000|
|Day's Range||0.08 - 0.09|
|52 Week Range||0.06 - 0.60|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.97|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|